Pat Fox Fulgham, M.D.

Pat Fox Fulgham, M.D.
Pat Fox Fulgham, M.D., D.A.B.U.
Appointment Request

Pat Fox Fulgham, M.D., D.A.B.U.

Medical Director for Urology Clinics of North Texas’ partnership with Mary Crowley Cancer Research Center

Diplomate, American Board of Urology
Fellow, American College of Surgeons

Dr. Pat Fulgham has been with Urology Clinics of North Texas for over 35 years providing care to patients in the surrounding communities. As of 1/1/2023 Dr. Pat Fulgham will be changing his professional role, becoming the Medical Director for Urology Clinics of North Texas’ partnership with Mary Crowley Cancer Research Center. While we know that his patients will be saddened by his transition, we at UCNT look forward to his contribution in this new role.

Medical Practice

  • 1987-Present, Urology Clinics of North Texas, Dallas

Languages

  • English, German, Spanish

Board Certification

  • 1989 – Certification, American Board of Urology
  • 1997, 2006, 2017 – Recertification, American Board of Urology

Medical License

  • Texas, 1981

Education

  • 1981 – Doctor of Medicine, University of Texas, Southwestern Medical School
  • 1978 – Bachelor of Science (Summa Cum Laude), Texas A & M University
  • 1974 – L. V. Berkner High School (Salutatorian), Richardson, Texas

Postgraduate Training

  • 7/83-7/87: Urology Resident, University of Texas, Southwestern Medical School Affiliated Hospitals (Parkland Memorial Hospital, Dallas; V.A. Hospital; Children’s Medical Center; Baylor University Medical Center, Dallas, Texas)
  • 7/82-6/83: Surgical Resident, Parkland Memorial Hospital, Dallas, Texas
  • 7/81-6/82: Surgical Intern, Parkland Memorial Hospital, Dallas, Texas
  • 10/05: American College of Surgeons approved ultrasound instructor
  • 6/07: da Vinci ®/da Vinci S® Surgical System, Off-site Training Program for a Console Surgeon (Robotic Prostatectomy), Intuitive Surgical, Houston, TX

Certifications

  • Certified Instructor in Ultrasound, American College of Surgeons, 2005
  • Urologic Oncology, AUA Oncology Knowledge Assessment Test in Urology, 2007

Current Clinical/Administrative Positions

  • 2009-Present: Chairman, Department of Urology, Texas Health Presbyterian Dallas
  • 2001-Present: President Urology Research & Education Foundation 501(c)3
  • 1997-Present: Surgical Director of Oncology, Texas Health Presbyterian Dallas

Current Committees

  • 2011-Present: American Institute of Ultrasound in Medicine Clinical Standards Committee
  • 1992-Present: Medical Board, Texas Health Presbyterian Hospital Dallas
  • 2011-Present: Clinical Standards Committee, American Institute of Ultrasound in Medicine
  • 2005-Present: AUA Abstract Review Committee for annual AUA meeting
  • 2005-Present: AUA Office of Education Strategic Planning Committee
  • 1994-Present: Chairman, Cancer Committee, Texas Health Resources Presbyterian Dallas
  • 2009-Present: American College of Radiology Appropriateness Criteria Panel on Urology

Previous Committees

  • 2014-2020: American Urological Association Science and Quality Council
  • 2006-2016: AUA Urologic Diagnostic and Therapeutic Imaging Committee
  • 2011-2013: AUA Urologic Ultrasound Task Force: AUA/AIUM
  • 2010-2013: Vice-Chairman for Education, National Urologic Ultrasound Faculty
  • 2007-2013: AUA Urology Residency Core Curriculum Task Force
  • 2006-2013: American College of Radiology, Appropriateness Criteria Panel on Urology
  • 2007-2010: President, AUA National Urologic Ultrasound Faculty
  • 2006-2008: Chief Quality Officer, Urology Clinics of North Texas
  • 1998-2006: President, Urology Clinics of North Texas
  • 2004-2005: President, Texas Health Presbyterian Dallas Medical Staff
  • 2002-2005: Clinical Standards Committee, American Institute of Ultrasound in Medicine
  • 2002-2003: President, Texas Urological Society
  • 2001-2003: Chairman, Education Committee, Texas Urological Society
  • 1994-2002: Chairman, Department of Urology, Texas Health Presbyterian Dallas
  • 1998-2002: Clinical Associate Professor, Dept of Urology, Univ of Texas Southwestern Medical School, Dallas, Texas
  • 1994-2002: Chairman, Department of Urology, Texas Health Presbyterian Dallas
  • 1987-1998: Clinical Assistant Professor, Dept of Urology, Univ of Texas Southwestern Medical School, Dallas, Texas

Standards and Guidelines Panels

  • 2018/2019 AUA Standard Operating Procedure for Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. A Collaborative Initiative by the American Urological Association and the Society of Abdominal Radiology Prostate Disease Focus Panel.
  • American College of Radiology: Panel member. Appropriateness Criteria for Urologic Imaging (2009-present) http://www.acr.org
  • American Institute of Ultrasound in Medicine: Clinical Standards Committee. Ultrasound in the Practice of Urology (2011-2018). Development of accreditation program for urology practices
    (2012, rev. 2017) http://www.aium.org
  • American Urological Association. Panel Chairman. Clinical Effectiveness Protocols in the Management of Ureteral Calculus Disease (2012)
    http://www.auanet.org/content/media/imaging_assessment.pdf
  • European Association of Urology Guidelines Panel on Imaging (2013)

Honorary Memberships and Awards

  • 1998-2019: D-Magazine, Best Doctors in Dallas
  • 2004-2019: Texas Monthly, Super Doctors in Texas
  • 2008: Distinguished Service Award, American Urological Association
  • 2008: Health Care Hero Award, Dallas Business Journal
  • 2006: Presbyterian Hospital of Dallas, Leadership in Cancer Award
  • 2004: Silver Award for Best On Line Health Information 2004, editorial contribution to the American Urological Association for Urologyhealth.org
  • 2004: Katy Award 2004 for excellence in broadcasting and electronic media, public service announcement on prostate cancer prevention
  • 1994: A.F.U.D./AUA/Searle Office Based Research Award. Project: A relational database addressing the clinical and economic consequences of strategies for the early detection of prostate cancer.
  • 1983: American Urologic Association, South Central Section, Essay Contest, First prize, Clinical Research
  • 1980: Eaton Fellowship in Urology
  • 1978-1979: Texas Merit Scholarship, Southwestern Medical School
  • 1978: Leland Fikes Scholarship, Southwestern Medical School
  • 1974-1977: James W. Aston Presidents Endowed Scholar, Texas A & M University
  • 1974: National Merit finalist

Professional Societies

  • The Society of Urologic Oncology
  • American Urological Association
  • American Institute of Ultrasound in Medicine
  • European Association of Urology

Grants

  • 2009: A Prospective, Non-randomized, Single-center Feasibility Study Examining the Use of Ultrasound to Visualize the S3 Sacral Foramina. Role: Primary Investigator. Institution: Urology Research & Education Foundation. IRB: Texas Health Research Institute
  • 2006: Micro-RNAs for Diagnosis, Prognosis and Experimental Therapy of Human Prostate Cancer: A Pilot Study. Institution: Mary Crowley Medical Research Center and Urology Research & Education Foundation. Role: Principle Investigator. 2006
  • 2002: Seeger Grant, Baylor University Medical Center Foundation: Development of a Relational Database for the Management of Patients with Adenocarcinoma of
    the Prostate
  • 1994: American Foundation for Urologic Disease Office-Based Research Award Long-term evaluation of patient population via an interactive database to determine clinical outcomes and economic consequences of the use of transrectal ultrasound

Journal Reviewer

  • British Journal of Urology
  • Journal of Endourology
  • Journal of Ultrasound in Medicine Journal of Urology
  • Urology
  • Kidney International
  • Urologic Oncology: Seminars and Original Investigations.
  • Urology Practice Journal
  • World Journal of Urology

Teaching Experience

  • Director, Post-Graduate Course AUA Annual Meeting, 2017-2021. Multi-parametric Ultrasound in the Diagnosis of Prostate Cancer
  • Course Director, AUA Hands-On Ultrasonography for Urologists. American Urological Association Office of Education. 2001-2019
  • 71st Congress of German Society of Urology Association. The Myth of Systematic Biopsy. September 2019, Hamburg, Germany.
  • UroAktuell 2018: Current and practical relevance in urology. Dresden, Germany, April 2018. (1) Optimizing Gray-Scale Imaging in the Diagnosis of Prostate Cancer. (2) Comparison of methods: targeting vs. systematic, significant vs. insignificant
  • World Federation of Ultrasound in Medicine and Biology Congress 2017. TRUS in USA and Ultrasound Education. Multiparametric Ultrasound Performs as Well as Multiparametric MRI for Prostate Cancer. October 2017
  • Course Director: Advanced Urologic Ultrasound with Hands-On Lab. AUA Annual Meeting 2011-2014

AUA Annual Meeting Plenary Sessions

  • 2016: Point Counterpoint: Testis Cancer Surveillance: Low-Dose CT is Better Than MRI.
  • 2014: Standardized Nomenclature for Imaging in Urology: A Joint Project of the European Association of Urology Guideline Office and the American Urological Association Urologic Diagnostic and Therapeutic Imaging Committee.
  • 2012: Use of Imaging in the Management of Ureteral Calculus Disease.
  • 2010: Is there Overutilization of Imaging in Urology?
  • 2007: Threats to Imaging in Urology.
  • Faculty, AUA Post Graduate Course on Pelvic Ultrasound: AUA Annual Meeting, 2012-2013, 2016.
  • Cancer Symposium, Texas Health Presbyterian Hospital Dallas, June 2016. The Quantum Theory of Prostate Cancer Screening. Urology Research & Education Foundation annual lecture, October 2009-2015.
  • Instructor, post-graduate course on pelvic ultrasound. Urological Society of Australia and New Zealand. Gold Coast Australia, April 2015.
  • Society of University Urologists, May 2012, Implications of Resident Requirements for the Documentation of Imaging: The Importance of Formal Ultrasound Training in Residency: Impact on Subsequent Practice.
  • Ultrasound Instructors Course: AUA Annual Meeting, May 2010, May 2011, May 2012.
  • Invited Lecture: Harry M. Spence Lecture, North Texas American College of Surgeons, Dallas, TX, February 2011. Image guided surgical procedures: What a surgeon should know.
  • Abdominal Ultrasound with hands-on instruction: AUA Northeastern Section, Pittsburg, PA. Sept 2010.
  • Scrotal Ultrasound with hands-on instruction: AUA South Central Section, White Sulphur Springs, WV, Sept 2010.
  • AUA Annual Meeting, Prostate Ultrasound Course, May 2010.
  • Abdominal Ultrasound with Hands-on instruction: AUA New England Section, Sept. 2009; South Central Section, Oct. 2009.
  • Scrotal Ultrasound with Hands-on instruction: AUA Western Section, Oct. 2009.
  • Course Director: Urologic Ultrasound with Hands-On Lab: AUA annual meeting, April 2009.
  • Society of Laparoendoscopic Surgeons, Image-Guided Surgical Procedures: What a Surgeon Should Know About Non-Surgical Approaches. Boston, 2009.
  • Incidental Renal Masses. 25th World Congress of Endourology & SWL. Cancun, Mexico. November 1, 2007.
  • Imaging Services: Certification and Training. AUA Western Section Annual Meeting. Phoenix, AZ. October 28, 2007.
  • AUA Ultrasound Instructors Course. Denver, CO. September 15, 2007, May 2008; AUA Chicago, 2009; Baltimore 2009; Dallas 2010.
  • Urologic Ultrasound for Residents. New York Academy of Medicine. New York, New York. August 24-25, 2007.
  • Controversy with Ultrasound. Texas Urologic Society Annual Meeting. Galveston, June 2007.
  • Basic Urologic Ultrasound. AUA Annual Meeting. Anaheim, CA. May 30, 2007.
  • Differential miRNA expression profiles in low-risk prostate cancer following radical prostatectomy. Mary Crowley Medical Research Center, 14th International Conference on Gene Therapy of Cancer. Dallas, TX. September 15, 2006.
  • Program Director: Cancer Management: Advances in the Diagnosis and Treatment.
  • February 4, 2006. Presbyterian Hospital of Dallas.
  • Advancing on all Fronts: Multimodality Therapy of Urologic Malignancies.
    February 4, 2006. Presbyterian Hospital of Dallas.
  • Office Ultrasound – Kidney, Bladder, Scrotum and Prostate. Post-graduate course,
    American Urological Association Annual Meeting, 2004-2007.
  • Visiting Professorship: Renal Ultrasound Imaging Course. University of California, Irvine. February 26-28, 2004.
  • Inhouse Pathology in the Urology Practice. Texas Urological Society. June 2003.
  • American Institute of Ultrasound in Medicine Annual meeting, March 2002, Nashville, Tennessee. Prostate Disease and Ultrasonography: Applications of Transrectal Ultrasonography.
  • Prostate Cancer: Current Concepts in Risk Reduction, Early Diagnosis and Treatment.
  • Cooper Clinic Grand Rounds. Dallas, TX. August 13, 2002.
  • Biopsy Outcomes and the Fate of Patients Undergoing Multiple Biopsies. Texas Urological Society Annual meeting. Galveston, Texas, June 2000.
    The Electronic Medical Record in the Urology Practice. Texas Urological Society Annual meeting. Galveston, Texas, June 2000.
  • Radioactive Seed Implantation as Salvage Therapy Following Failed External Beam Radiation for Prostate Cancer. Paul C. Peters Day, Dallas, Texas, October 2, 1999.
  • Seed Implantation for Prostate Cancer. Minimally Invasive Technologies: Medicine in the 21st Century. The Inaugural Symposium of the Presbyterian Institute for Minimally Invasive Technology (PIMIT), Texas Health Research Institute. Presbyterian Hospital of Dallas, May 15, 1999.
  • Genitourinary Cancer Update. Primary Care Update XXII. Presbyterian Hospital of Dallas, May 1, 1999.
  • Transrectal Ultrasonography, Beyond the Basics: Post Radical Prostatectomy, Seed Placement. Radioactive Seed Implantation for Prostate Cancer – Ultrasound Considerations. Hands On Ultrasonography Course. AUA Office of Education, Houston, Texas. Dec. 1998, July 1999.
  • BPH: Pitfalls and Pearls. Primary Care Update XIX. Presbyterian Hospital of Dallas. September 12, 1998.
  • The Appropriate Use of PSA in the Diagnosis and Management of Prostate Cancer. Treatment of Common Cancers for the Primary Care Physician. Presbyterian Hospital, Dallas, Texas May 1998.
  • Roehrborn, Claus, Fulgham, Pat F. Postgraduate Instructional Courses. Office Ultrasound.
  • AUA Annual Meetings, 1992-1998.
  • Roehrborn, Claus, Fulgham, Pat F. Office Ultrasound. Texas Urological Association Meeting, Arlington, TX. June 1997.
  • Clinical and Economic Consequences of PSA Testing for Prostate Cancer in Urologic Practice. Paul C. Peters Day. Dallas, TX. September 1994.
  • Fulgham, Pat F. Laparoscopic Pelvic Lymphadenectomy, Complications and Economic Consequences. World Congress of Endourology, St. Louis, MO. December, 1994.

Electronic Publications

  • Fulgham, Pat and Resnick, Martin. Guidelines for Ultrasound Utilization. American Urological Association. October 2001. Found on the World Wide Web at
    http://auanet.org/aboutaua/policy_statements/education.cfm#recommendations
  • Fulgham, Pat and Resnick, Martin. Recommendations for Urologic Office Ultrasound. American Urological Association. October 2001. Found on the World Wide Web at
    http://auanet.org/aboutaua/policy_statements/education.cfm#recommendations

Print Publications: Journals

  • Fulgham, PF. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer. World J Urol (2018). World J Urol, May 2018, Vol 36(5):713-718
    https://doi.org/10.1007/s00345-018-2187-9
    AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S. J Urol. 2017, October,
    198(4):832-837.
  • ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. J Am Coll Radiol. 2017
    May;14(5S):S245-S257. doi: 10.1016/j.jacr.2017.02.026.
  • ACR Appropriateness Criteria® Hematospermia. Expert Panel on Urologic Imaging:, Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. J Am Coll Radiol. 2017 May;14(5S):S154-S159. doi: 10.1016/j.jacr.2017.02.023.
  • Characterization of Renal Masses by Ultrasound. Fulgham PF. J Urol. 2017 Feb;197(2S):S121. doi: 10.1016/j.juro.2016.10.114. Epub 2016 Dec 20.
    Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow.
  • Loch T, Fulgham PF. Eur Urol. 2016 Jun;69(6):1034-6. doi: 10.1016/j.eururo.2015.11.015. Epub 2015 Dec 2.
  • Active surveillance redefines paradigm for prostate cancer management.
    HemOnc Today, September 25, 2015. Point/Counterpoint. http://goo.gl/6Qz9ts
  • Editorial: Journal of Endourology. Treatment of benign prostatic hyperplasia using transurethral split of the prostate surgery with a columnar balloon catheter. 2014
  • Loch, T, Carey, B, Walz, J, Fulgham, P F, & for the European Association of Urology Guidelines Office Ad Hoc Working Group on Urological Imaging. (2014). EAU Standardised Medical Terminology for Urologic Imaging: A Taxonomic Approach. European Urology. doi:10.1016/j.eururo.2014.08.014
  • Fulgham, PF, Assimos, DG, Pearle, MS, & Preminger, GM. (2013). Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. The Journal of Urology, 189(4), 1203–1213. doi:10.1016/j.juro.2012.10.031
  • Coursey, CA, Casalino, DD, Remer, EM, Arellano, RS, Bishoff, JT, Dighe, M, Fulgham, PF… (2012). ACR Appropriateness Criteria® acute onset flank pain–suspicion of stone disease. Ultrasound Quarterly, 28(3), 227–233. doi:10.1097/RUQ.0b013e3182625974
  • Remer, EM, Casalino, DD, Arellano, RS, Bishoff, JT, Coursey, CA, Dighe, M, Fulgham PF… (2012). ACR Appropriateness Criteria ® acute onset of scrotal pain–without trauma, without antecedent mass. Ultrasound Quarterly, 28(1), 47–51. doi:10.1097/RUQ.0b013e3182493c97
  • Casalino, DD, Remer, EM, Arellano, RS, Bishoff, JT, Coursey, CA, Dighe, M, Fulgham PF… (2011). ACR Appropriateness Criteria® posttreatment follow-up of prostate cancer. Journal of the American College of Radiology: JACR, 8(12), 863–871. doi:10.1016/j.jacr.2011.09.003
  • Fulgham, PF. (2011). Ultrasound-guided transrectal prostate biopsy. Urol List, 9(2), 18–23.
  • Fulgham, PF, Gilbert, BR, & Loughlin, KR. (2011). Re: Imaging use among employed and self-employed urologists. The Journal of Urology, 185(5), 1990–1991; author reply 1993–1994.
    doi:10.1016/j.juro.2011.03.011
  • Cho, JS, Fulgham, P, Clark, A, & Kavoussi, L. (2010). Followup imaging after urological imaging studies: comparison of radiologist recommendation and urologist practice. The Journal of Urology, 184(1), 254–257. doi:10.1016/j.juro.2010.03.016
  • Dighe, M, Francis, IR, Casalino, DD, Arellano, RS, Baumgarten, DA, Curry, NS, Fulgham PF. (2010). ACR appropriateness criteria on obstructive voiding symptoms secondary to prostate disease. Journal of the American College of Radiology: JACR, 7(4), 255–259. doi:10.1016/j.jacr.2009.12.004
  • Tong, AW, Fulgham, P, Jay, C, Chen, P, Khalil, I, Liu, S, … Nemunaitis, J. (2009). MicroRNA profile analysis of human prostate cancers. Cancer Gene Therapy, 16(3), 206–216. doi:10.1038/cgt.2008.77
  • Jay, C, Nemunaitis, J, Chen, P, Fulgham, P, & Tong, A. (2007). miRNA profiling for diagnosis and prognosis of human cancer. DNA and Cell Biology, 26(5), 293–300. doi:10.1089/dna.2006.0554
  • Fulgham, PF. (2006). The continuing search for meaningful prognostic information from prostate biopsy. The Journal of Urology, 175(1), 16–17. doi:10.1016/S0022-5347(05)00256-9
  • Fulgham, P & Jensen, P. (2006). Sonographic appearance of isolated necrotizing vasculitis of the testis. Journal of Clinical Ultrasound: JCU, 34(2), 99–107. doi:10.1002/jcu.20205
  • Fulgham, P. (2005). Can ultrasound measurement of residual bladder volume be improved with a novel, personalized algorithm? Nature Clinical Practice. Urology, 2(3), 130–131. doi:10.1038/ncpuro0116
  • Fulgham, PF, Cochran, JS, Denman, JL, Feagins, BA, Gross, MB, Kadesky, KT, Roehrborn, CG. (1998). Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. The Journal of Urology, 160(6 Pt 1), 2041–2046.
  • Resnick, MI, Fulgham, PF, Herbener, T & Roehrborn, CG. (1993). Office ultrasound, from the kidney to the urethra. Contemporary Urology, 5(2), 25–40.
  • Kadesky, KT & Fulgham, PF. (1993). Bilateral multifocal renal oncocytoma: case report and review of the literature. The Journal of Urology, 150(4), 1227–1228.
  • Fulgham, PF & Feagins BA. (1993). Laparoscopic pelvic lymphadenectomy in the staging of adenocarcinoma of the prostate. Infections in Urology, 6(2), 44–47.
  • Morris, JS, Husmann, DA, Wilson, WT, Denstedt, J, Fulgham, PF, Clayman, RV & Preminger, GM. (1991). A comparison of renal damage induced by varying modes of shock wave generation. The Journal of Urology, 145(4), 864–867.
  • Loch, T, Gettys, T, Cochran, JS, Fulgham, PF & Bertermann, H. (1990). Computer-aided image analysis in transrectal ultrasound of the prostate. World Journal of Urology, 8(3), 150–153.
    doi:10.1007/BF01576761
  • Roehrborn, CG, Chinn, HK, Fulgham, PF, Simpkins, KL & Peters, PC. (1986). The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. The Journal of Urology, 135(6), 1190–1193.

Print Publications: Books

  • Practical Urologic Ultrasound, Co-Editors Pat Fulgham MD, Bruce Gilbert MD. Publisher: Springer. First Edition May 2013, Second Edition 2017, Third Edition 2020.
  • Interventional Urology Editors: Rastinehad, A.R., Siegel, D.N., Pinto, P.A., Wood, B.J. (Eds.). 2016. Ch. 6, Transrectal ultrasound of the prostate. Gideon D. Richards, Pat F. Fulgham and Bruce Gilbert.
  • Campbell-Walsh Urology 11th Edition, Urinary Tract Imaging: Basic Principles of Urologic Ultrasonography, 2015
    Pelvic Floor Ultrasound. Springer. Physics of ultrasound. Springer. 2015
  • Prostate Ultrasound: Current Practice and Future Directions. Chapter contributor:
  • Prostate Artifacts. Publisher: Springer. Due 2014
  • Ultrasound of Male Genitalia. Chapter co-author: Physics of Ultrasound. Publisher: Springer. Due 2014.
  • Campbell-Walsh Urology, 10th ed. Chapter 4: Urinary tract imaging: Basic principles and safety. 2011
  • Guest editor, Urology Clinics of North America, Urologic Imaging. Elsevier. August 2006

Abstracts

  • Shen Yunhe, Fulgham Pat, Zhou Xiangmin, Burke Daniel, Sweet Robert. The Wii Transrectal Ultrasonography Simulator. Department of Urologic Surgery, University of Minnesota Medical School. AUA Annual Meeting, San Francisco, May 2010
  • Cho JS, Fulgham PF, Clark AR, Kavoussi LR. Radiographic studies: Comparison of radiologists’ recommendation and urologists’ practice. Published in J Urology April 2009 and presented at 2009 AUA Annual Meeting.
  • Pat Fulgham, Chris Jay, Patrick Chen, Jian Han, Alex W Tong, Neil Senzer and John Nemunaitis. Huntsville, AL. Differential miRNA expression profiles in low-risk prostate cancer following radical prostatectomy. 14th International Conference on Gene Therapy. Sept. 2006
    Fulgham, Pat F, Clark, Angela R. The outcome of subsequent biopsy in patients with prostatic intraepithelial neoplasia (PIN). Poster Presentation at the AUA meeting in Atlanta, Georgia, May 2000. Abstract sequence #: 1237.
  • Fulgham, Pat F. Increased incidence of prostatic intraepithelial neoplasia on prostate biopsy and the likelihood of the subsequent diagnosis of prostate cancer. Presented at the AUA South Central Section meeting, Santa Fe, NM, September 1999.
  • Fulgham, Pat F, Cochran, James S., Denman, John, L., Feagins, Brian A., Gross, Michael B., Kadesky, Keith T., Kadesky, Melvin C., Clark, Angela, Roehrborn, Claus G. (Presented by Dr. Fulgham,) Disappointing Results with Transurethral Alprostadil in Men with Erectile Dysfunction (ED) in Urology. Presented at the AUA meeting, San Diego, June 1998.
  • Fulgham, Pat F., Pollock, Mark, Clark, Angela. The Application of Image Recognition Technology to the Ultrasonographic Diagnosis of Prostate Cancer. Presented at the AUA South Central Section, Bermuda, November 1997.
  • Fulgham, Pat F., Feagins, Brian A., Roehrborn, Claus G., Cochran, James S., Kadesky, Melvin C., Denman, John L., Harrison, III, Clanton B. ROC Curve Analysis of the Performance of Digital Rectal Examination (DRE) and Prostate Specific Antigen (PSA) in the Early Detection of Prostate Cancer. Presented at the AUA South Central Section Meeting, Vancouver, British Columbia, August 1994.
  • Fulgham, Pat F., Cochran, James S., Roehrborn, Claus G., Feagins, Brian A., Kadesky, Melvin C., Denman, John L., Harrison, III, Clanton B. Effect of the Application of Age-Specific Reference Ranges for Prostate Specific Antigen (PSA) on Biopsy and Cancer Detection Rates in a Well-Defined Population. Presented at the AUA South Central Section Meeting, Vancouver, British Columbia August 1994.
  • Fulgham, Pat F., Cochran, James S., Denman, John L., Harrison, Clanton B., Clark, Angela R., Kurtz, Helen S. and Kadesky, Melvin C.: The Effect of Previous Vasectomy on the Early Detection of Prostate Cancer in 2300 Patients. Presented AUA Annual Meeting, San Francisco, CA, 1994.
  • Fulgham, Pat F., Feagins, Brian A., Cochran, James S., Kadesky, Melvin C., Denman, John L., and Harrison, Clanton B.: Cost Analysis of Laparoscopic Lymphadenectomy in a Private Practice Setting. AUA Annual Meeting, San Antonio, TX, 1993.
  • Loch T, Bertermann H, Gettys T, Cochran J, Fulgham P: Image Analysis System (IAS): Objective Ultrasound Image Analysis Leads to Prostate Cancer Characterization. Poster presented at the Pat Fox Fulgham, MD Rev. June 2020
  • American Urological Association Annual Meeting at New Orleans, LA, 1990.
    Cochran J.S., Fulgham, P.F., Kadesky, M.C., Denman, J.L.: Computer Assisted Image Analysis of Prostate Ultrasound in the Diagnosis of Carcinoma of the Prostate. Poster presented at the American Urological Association Annual Meeting at Dallas, Texas, 1989.
  • Morris, J.S., Husmann, D.A., Wilson, W. T., Fulgham, P.F., Preminger, G.M.: Piezoelectric vs. Spark-Gap Lithotripsy: A Comparison of Morphologic and Functional Alterations. Submitted American Urological Association, Inc., Baltimore, Maryland, 1988.
  • Miller, G.L., Wilson, W.T., Fulgham, P.F., McDougall, L.L., Erdman, W.A., Preminger, G.M.: Morphologic Renal Changes Following Piezoelectric and Spark-Gap Lithotripsy. Submitted American Urological Association, Inc. Baltimore, Maryland, 1988.
  • Fulgham, P.F., Clayman, R.V., Peters, P.C.: Radiation Exposure During Percutaneous Endourologic Procedures: Problems and Precautions. Abstracts of the American Urologic Association #414, 1985.
  • Fulgham, P.F., Sagalowsky, A.I.: Percutaneous Renal Procedures in Renal Transplant Patients. Presented at the South Central Section, American Urologic Association, Guadalajara, Mexico, 1985.
  • Fulgham, P.F.: Radiation Dosages to Staff During Percutaneous Endourologic Procedures. Submitted Resident’s Essay Contest, South Central Section. American Urologic Association, St. Louis, Mo., 1983.

Videos, Radio, TV

  • Educational video: Advanced Urologic Ultrasound. Produced by the American Urological Association. June 2014
  • NBC5 Street Talk with Scott Murray, aired May 23, 2009 at 1:00 p.m. Topic: Prostate cancer screening.
  • Discovery Health: Aired July 2009. Prostate cancer prevention using finasteride.
  • Educational videos on Abdominal Ultrasound and Prostate Ultrasound. Produced for the American Urologic Association in May 2008. Video offers the opportunity for urologists to receive AMA CME Level 2 verification after successful completion of post-course examination.
    Educational video: Basic Urologic Ultrasound. Produced for the American Urological Association. July 2007. Video offers the opportunity for urologists to receive AMA CME Level 2 verification after successful completion of post-course examination. Revised May 2011.
  • Educational Video: Ultrasound Machine Operations. Produced for the American Urological Association, Office of Education. January 2004.
  • Educational Video: Scrotal Ultrasound, Bladder Ultrasound, Renal Ultrasound, Prostate Ultrasound. Produced for American Urological Association, Office of Education. September 2002.
  • Patient Education Video: Prostate Cancer: Diagnosis and Treatment Options. June 1999.
  • Patient Education Video: Vasectomy. June 1996.
  • Prostate Cancer. WFAA Channel 8 (ABC) News in Dallas. December 2003.
  • Exercise and Male Sexual Health. KDFW Fox4News in Dallas with John Hammerly. Jan 30-31,2003.
  • Prostate Cancer discussion. Cooper Wellness Radio Show. National and local. Kenneth Cooper, M.D. and Todd Whitthorne. KRLD Studios. Arlington, TX. August 17, 2002, September 7, 2002, August 2003, January 2004, May 2007.

Completed Research Studies

  • Prostate Cancer Prevention: (HGPIN study)
    SWOG 9917: L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High Grade Prostatic Intraepithelial NeoplasiaUrology-Benign Prostatic Hypertrophy
    An Eleven-Week, Open-Label, Randomized, Multicenter, Parallel-Design, Placebo Lead-In Study of XXXX Capsules, 0.4 mg Daily vs. XXXXX Capsules, 5 mg (with XXXXX) Daily in Patients with the Signs and Symptoms of Benign Prostatic Hyperplasia. Role: Sub-investigator. Institution: Presbyterian Hospital of Dallas.
  • Prostate Cancer Prevention: Rofecoxib (ViP study)
    Double blind, randomized, placebo-controlled multicenter study to evaluate the effects of Rofecoxib in Decreasing the Risk of Prostate Cancer. Sponsor: Merck & Co. Inc. SWOG. Principal investigator. Institution: Presbyterian Hospital of Dallas. Role: Principle investigator
  • Prostate Cancer Prevention: Proscar (PCPT Trial)
    Prostate Cancer Prevention Trial. 10 year trial. SWOG. Principal investigator. Study ended May 2003. Role: Principle investigator. Institution: Presbyterian Hospital of Dallas.
  • Bladder Cancer
    Phase IIb/III Chemoprevention Trial of XXXXXX to Prevent Recurrence of Superficial Bladder Cancer. Role: Primary investigator. Institution: Urology Clinics of North Texas / THRI.
  • Urology-Benign Prostatic Hypertrophy
    A Phase II/III, Double-Blind, Placebo Controlled, Dose-Finding Study of the Safety and Efficacy of XXXXX in Patients with Symptomatic Benign Prostatic Hyperplasia (BPH).
    Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Bladder Cancer
    Phase III Randomized, Double-Blind Study of XXXXX vs. Placebo in Low Grade Superficial Bladder Cancer. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Chronic Prostatitis
    A Randomized, Double-Blind, Multicenter, Phase III Study of XXXXX and XXXXX in the Treatment of Chronic Bacterial Prostatitis. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Erectile Dysfunction (Organic)
    Open-Label Study of the Efficacy and Safety of an Aqueous XXXXX Topical Cream in the Treatment of Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Erectile Dysfunction (Organic)
    Phase III, Efficacy and Safety of an Aqueous XXXXX Topical Cream in the Treatment of Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Impotence
    A Phase III at Home Use Study Evaluating the Efficacy and Safety of Escalating Doses of XXXXX 2, 3, and 4 mg in the Treatment of Patients with Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Impotence
    A Pilot Study Evaluating the Safety and Efficacy of XXXXX in Combination with XXXXX in the Treatment of Male Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Impotence
    Screening Protocol for Identification of Patients with Erectile Dysfunction for Participation in XXXXX, Twelve-Week, Double-Blind, Efficacy and Safety Study of Oral XXXXX, Oral XXXXX vs. Placebo for the Treatment of Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Impotence
    A Double-Blind, Twelve-Week Comparative Efficacy and Safety Study of Oral XXXXX, Oral XXXXX vs Placebo in Patients with Erectile Dysfunction. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Prostate Cancer
    A Phase 3, Multicenter, Open-Label Randomized Study of XXXXXg vs XXXXX in Patients with Prostate Cancer Who are Candidates for Initial Hormonal Therapy. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Questionnaire
    Anxiety Questionnaire in Men with Prostate Cancer. Role: Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • Urology-Urge Urinary Incontinence
    An Open Label Study to Evaluate Patient Acceptance and Safety of XXXXX in Urge Urinary Incontinence. : Sub-investigator. Institution: Urology Clinics of North Texas / THRI
  • CaPSURE™ (Cancer of the Prostate Strategic Urologic Research Endeavor) 1990-present CaPSURE™ is a longitudinal observational study of prostate cancer patients nationwide. The CaPSURE™ database is managed by the Urology Outcomes Research Group of the UCSF Department of Urology, San Francisco, CA, and sponsored by TAP Holdings Inc., Deerfield, IL. : Sub-investigator. Institution: Urology Clinics of North Texas / THRI
Urology Clinics of North Texas

UCNT will be closed for the Thanksgiving Holiday on
Thursday 11/23 & Friday 11/24

We at Urology Clinics of North Texas would like to wish you a very Happy Thanksgiving Holiday! We will return to normal Business hours on Monday, November 27, 2023.